Veritas Capital

Veritas Capital is a private equity investor whose strategic identity is built around the intersection of technology and government, and the firm’s healthcare engagement applies that lens to the public-sector edge of healthcare software. From its New York base, Veritas backs growth-stage companies whose products serve federal health agencies, state Medicaid programs, public health systems, and the broader infrastructure that supports them. For founders, this is later-stage capital with an unusually specialist orientation toward the public sector rather than a generalist growth check.

The thesis is healthcare software, with the explicit specialization that the relevant companies operate at the intersection of healthcare and government. AI focus is real and reflects the increasing role of AI in public-sector healthcare workflows, with the underlying diligence framework grounded in the realities of federal procurement, regulatory compliance, and the long sales cycles characteristic of government buyers. Founders without a clear public-sector or government-adjacent thesis are typically a less natural fit; founders with one should expect a specialist investor with unusually deep institutional relationships.

Checks fall in the twenty-five million dollar plus range at the growth stage, which positions Veritas as a significant minority or control investor in companies with substantial existing public-sector revenue. Geography is centered on the United States, with Washington-area institutional relationships often mattering as much as the firm’s New York operating base.

The firm is a specialist private equity investor rather than a generalist platform, and its team includes operating partners and advisors with deep federal and government experience. That depth is the central feature of the engagement and is part of what founders are evaluating when they take Veritas capital.

The approach is sector-specific and operationally embedded in the public sector. The firm is most useful on questions of federal and state procurement, the build-out of commercial organizations capable of selling and supporting public-sector contracts at scale, the navigation of compliance and security requirements that shape government healthcare technology, and the long-term work of consolidating fragmented public-sector software businesses. Process is rigorous and reflects the firm’s PE discipline: detailed diligence on contracts and pipeline, structured term negotiations, and an explicit operating plan. Follow-on capital is part of the firm’s strategy and consistent with its growth-stage focus. The trade-offs for founders are the usual specialist-PE concerns: governance shifts, an explicit focus on disciplined milestone execution, and a clearer eventual exit horizon. For healthcare software founders building at the public-sector edge of the market, the proposition is specific and well-tested.